A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial1 | Zendy

Giovanni Abbruzzese | Zendy; Jaime Kulisevsky | Zendy; Bruno Bergmans | Zendy; Juan Carlos GómezEsteban | Zendy; Georg Kägi | Zendy; Jason Raw | Zendy; Ambra Stefani | Zendy; Tobias Warnecke | Zendy; Wolfgang H. Jost | Zendy

Open Access

A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial1

Author(s) -

Giovanni Abbruzzese,

Jaime Kulisevsky,

Bruno Bergmans,

Juan Carlos GómezEsteban,

Georg Kägi,

Jason Raw,

Ambra Stefani,

Tobias Warnecke,

Wolfgang H. Jost

Publication year - 2020

Publication title -

journal of parkinson s disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.747

H-Index - 45

eISSN - 1877-718X

pISSN - 1877-7171

DOI - 10.3233/jpd-202224

Subject(s) - medicine , adverse effect , observational study , parkinson's disease , cohort , cohort study , retrospective cohort study , pediatrics , disease

Safinamide modulates both dopaminergic and glutamatergic systems with positive effects on motor and non-motor symptoms of Parkinson's disease (PD). The drug utilization study SYNAPSES was designed to investigate the use of safinamide in routine clinical practice, as recommended by the European Medicines Agency.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research